Serum autoantibody profiling using a natural glycoprotein microarray for the prognosis of early melanoma

Journal of Proteome Research

Volumn 9, Issue 11, 2010, Pages 6044-6051

  Liu, Yashu ^a   He, Jintang ^a   Xie, Xaiolei ^a   Su, Gang ^a   Teitz Tennenbaum, Seagal ^a   Sabel, Michael S ^a   Lubman, David M ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

autoantibody profiling; melanoma prognosis; natural glycoprotein microarray

Indexed keywords

ACID CERAMIDASE; AUTOANTIBODY; CATHEPSIN D; GLUCOSE REGULATED PROTEIN 94; GLYCOPROTEIN; LACTATE DEHYDROGENASE; LECTIN; PYROXYLIN; RECOMBINANT PROTEIN;

ADULT; AFFINITY CHROMATOGRAPHY; AGED; AMINO ACID SEQUENCE; ARTICLE; CANCER STAGING; CELL LINE; DISEASE MARKER; EARLY CANCER; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; MALE; MELANOMA; MELANOMA CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AUTOANTIBODIES; CELL LINE, TUMOR; EARLY DETECTION OF CANCER; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MELANOMA; MICROARRAY ANALYSIS; MIDDLE AGED; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 78149388019     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100856k     Document Type: Article

References (32)

1. Jerant, A. F.; Johnson, J. T.; Sheridan, C. D.; Caffrey, T. J. Early detection and treatment of skin cancer Am. Fam. Physician 2000, 62 (2) 357-368
2. Jemal, A.; Seigel, R.; Ward, E.; Hao, Y.; Xu, J.; Thun, M. J. Cancer Statistics, 2009 CA Cancer J. Clin. 2009, 59, 225-249
3. Morton, D. L.; Thompson, J. F.; Cochran, A. J.; Mozzillo, N.; Elshoff, R.; Essner, R.; Nieweg, O. E.; Roses, D. F.; Hoekstra, H. J. Sentinel-node biopsy or nodal observation in melanoma N. Engl. J. Med. 2006, 355 (13) 1307-1317
4. Blazer, D. G.; Sondak, V. K.; Sabel, M. S. Surgical therapy of cutaneous melanoma Semin. Oncol. 2007, 34, 270-280
5. Ulevitch, R. J. Therapeutics targeting the innate immune system Nat. Rev. Immunol. 2004, 4 (7) 512-520
6. Pollard, K. M.; Lee, D. K.; Casiano, C. A.; Bluthner, M.; Johnston, M. M.; Tan, E. M. The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular and antigenic properties J. Immunol. 1997, 158 (7) 3521-3528
7. Dunn, G. P.; Bruce, A. T.; Ikeda, H.; Old, L. J.; Schreiber, R. D. Cancer immunoediting: from immunosurveillance to tumor escape Nat. Immunol. 2002, 3 (11) 991-998
8. Shankaran, V.; Ikeda, H.; Bruce, A. T.; White, J. M.; Swanson, P. E.; Old, L. J.; Schreiber, R. D. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity Nature 2001, 410 (6832) 1107-1111
9. Rudd, P. M.; Elliott, T.; Cresswell, P.; Wilson, I. A.; Dwek, R. A. Glycosylation and the immune system Science 2001, 291 (5512) 2370-2376
10. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 1976, 72, 248-254
11. Keller, A.; Nesvizhskii, A. I.; Kolker, E.; Aebersold, R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search Anal. Chem. 2002, 74 (20) 5383-5392
12. Nesvizhskii, A. I.; Keller, A.; Kolker, E.; Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry Anal. Chem. 2003, 75 (17) 4646-4658
13. Patwa, T. H.; Li, C.; Poisson, L. M.; Kim, H. Y.; Pal, M.; Ghosh, D.; Simeone, D. M.; Lubman, D. M. The identification of phosphoglycerate kinase-1 and histone H4 autoantibodies in pancreatic cancer patient serum using a natural protein microarray Electrophoresis 2009, 30 (12) 2215-2226
14. Iskratsch, T.; Braun, A.; Paschinger, K.; Wilson, I. B. Specificity analysis of lectins and antibodies using remodeled glycoproteins Anal. Biochem. 2009, 386 (2) 133-146
15. Wang, Y.; Ao, X.; Vuong, H.; Konanur, M.; Miller, F. R.; Goodison, S.; Lubman, D. M. Membrane glycoproteins associated with breast tumor cell progression identified by a lectin affinity approach J. Proteome Res. 2008, 7 (10) 4313-4325
16. Kung, L. A.; Tao, S. C.; Qian, J.; Smith, M. G.; Snyder, M.; Zhu, H. Global analysis of the glycoproteome in Saccharomyces cerevisiae reveals new roles for protein glycosylation in eukaryotes Mol. Syst. Biol. 2009, 5, 308
17. Li, Z.; Dai, J.; Zheng, H.; Liu, B.; Caudill, M. An integrated view of the roles and mechanisms of heat shock protein gp96-peptide complex in eliciting immune response Front. Biosci. 2002, 7, d731-751
18. Martinez, J.; Perez-Serrano, J.; Bernadina, W. E.; Rodriguez-Caabeiro, F. HSP60, HSP70 and HSP90 from Trichinella spiralis as targets of humoral immune response in rats Parasitol. Res. 2001, 87 (6) 453-458
19. Parmiani, G.; De Filippo, A.; Pilla, L.; Castelli, C.; Rivoltini, L. Heat shock proteins gp96 as immunogens in cancer patients Int J Hyperthermia 2006, 22 (3) 223-227
20. McCarthy, M. M.; Pick, E.; Kluger, Y.; Gould-Rothberg, B.; Lazova, R.; Camp, R. L.; Rimm, D. L.; Kluger, H. M. HSP90 as a marker of progression in melanoma Ann. Oncol. 2008, 19 (3) 590-594
21. Graner, M. W.; Bigner, D. D. Chaperone proteins and brain tumors: potential targets and possible therapeutics Neuro Oncol. 2005, 7 (3) 260-278
22. Han, J. M.; Kwon, N. H.; Lee, J. Y.; Jeong, S. J.; Jung, H. J.; Kim, H. R.; Li, Z.; Kim, S. Identification of gp96 as a novel target for treatment of autoimmune disease in mice PLoS One 2010, 5 (3 e9792
23. Raisova, M.; Goltz, G.; Bektas, M.; Bielawska, A.; Riebeling, C.; Hossini, A. M.; Eberle, J.; Hannun, Y. A.; Orfanos, C. E.; Geilen, C. C. Bcl-2 overexpression prevents apoptosis induced by ceramidase inhibitors in malignant melanoma and HaCaT keratinocytes FEBS Lett. 2002, 516 (1-3) 47-52
24. Podhajcer, O. L.; Bover, L.; Bravo, A. I.; Ledda, M. F.; Kairiyama, C.; Calb, I.; Guerra, L.; Capony, F.; Mordoh, J. Expression of cathepsin D in primary and metastatic human melanoma and dysplastic nevi J. Invest. Dermatol. 1995, 104 (3) 340-344
25. Franzke, A.; Probst-Kepper, M.; Buer, J.; Duensing, S.; Hoffmann, R.; Wittke, F.; Volkenandt, M.; Ganser, A.; Atzpodien, J. Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma Br. J. Cancer 1998, 78 (1) 40-45
26. Egberts, F.; Hitschler, W. N.; Weichenthal, M.; Hauschild, A. Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapse Melanoma Res. 2009, 19 (1) 31-35
27. Ding, C.; Wang, L.; Marroquin, J.; Yan, J. Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1 Blood 2008, 112 (7) 2817-2825
28. Iwashiro, M.; Messer, R. J.; Peterson, K. E.; Stromnes, I. M.; Sugie, T.; Hasenkrug, K. J. Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection Proc. Natl. Acad. Sci. U.S.A. 2001, 98 (16) 9226-9230
29. Lizee, G.; Radvanyi, L. G.; Overwijk, W. W.; Hwu, P. Immunosuppression in melanoma immunotherapy: potential opportunities for intervention Clin. Cancer Res. 2006, 12 (7) 2359s-2365s
30. Rabinovich, G. A.; Gabrilovich, D.; Sotomayor, E. M. Immunosuppressive strategies that are mediated by tumor cells Annu. Rev. Immunol. 2007, 25, 267-296
31. Dunn, G. P.; Old, L. J.; Schreiber, R. D. The three Es of cancer immunoediting Annu. Rev. Immunol. 2004, 22, 329-360
32. Qiu, J.; Madoz-Gurpide, J.; Misek, D. E.; Kuick, R.; Brenner, D. E.; Michailidis, G.; Haab, B. B.; Omenn, G. S.; Hanash, S. Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens J. Proteome Res. 2004, 3 (2) 261-267